Callan JMB Supports U.S. Scale-Up of Multi-Indication Immune Platform with Phase 2b/3 Advancement
Keyword: Supply Chain Logistics
Independent oversight reinforces manufacturing, supply chain integrity, and federal readiness for a platform designed to scale across multiple indications
SPRING BRANCH, Texas, March 27, 2026 (GLOBE… [+8321 chars]
Read Full Story ↗
Related Content
-
Related Story Unipart announces strong 2025 financial results
-
Related Story Unipart announces strong 2025 financial results
SaaS Metrics